Journal profile · Peripheral Vascular Disease
Journal of Hypertension
ISSN 0263-6352 · eISSN 1473-5598 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly
Journal of Hypertension: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.24; JCR Q1 (journal website); hybrid open access; median 125 days to acceptance (27 articles, last 24 months); community-reported acceptance: about 50%; 1,095 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Hypertension is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention and Hormonal Regulation and Hypertension, together about 41.7% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
An updated meta-analysis targeting the prevalence of left ventricular hypertrophy (LVH), a cardinal marker of hypertensive heart disease (HHD), over the last 15 years is lacking. Thus, we analyzed the literature in order to provide a comprehensive information on LVH prevalence, as assessed by echocardiography, in the hypertensive setting.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Anthony M. HeagertyPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine24.5%
- Cardiovascular Health and Disease PreventionMedicine9.1%
- Hormonal Regulation and HypertensionMedicine8.1%
- Heart Rate Variability and Autonomic ControlMedicine5.8%
- Sodium Intake and HealthNursing5.4%
- Renin-Angiotensin System StudiesMedicine5.2%
- Cardiovascular Disease and AdiposityMedicine4.7%
- Cardiovascular Function and Risk FactorsMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · PERIPHERAL VASCULAR DISEASE · rank 16/100
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.24LetPub ·
- Impact factor (publisher)
- 5.6Publisher website ·
- CiteScore 2026-06
- 7.1LetPub ·
- SJR 2026-06
- 1.07LetPub ·
- SNIP 2026-06
- 1.76LetPub ·
- h-index
- 160LetPub ·
- h-index
- 238OpenAlex ·
- i10-index
- 8,833OpenAlex ·
- 2-year mean citedness
- 0.66OpenAlex ·
- Self-citation rate
- 5.4%LetPub ·
- Share of gold OA articles
- 28.35%LetPub ·
Volume
- Articles per year
- 223LetPub ·
- Articles per year (publisher)
- 1Publisher website ·
Articles by year OpenAlex count · 40,818 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 903 | 62 | 66 |
| 2025 | 1,095 | 102 | 642 |
| 2024 | 1,586 | 120 | 1,668 |
| 2023 | 2,537 | 127 | 6,765 |
| 2022 | 1,228 | 151 | 3,793 |
| 2021 | 1,675 | 131 | 5,353 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
125 daysMedian, submission to acceptance · P25–P75 93 days – 187 days
- Acceptance to online
- median 28 days (27 articles)
- Submission to online
- median 167 days
- Sample
- 27 articles with submission and acceptance dates (2,089 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- ISSN
- 0263-6352
- Electronic ISSN
- 1473-5598
- Latest issue on the website
- Volume 44, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Hypertension
What CAS zone is Journal of Hypertension in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Hypertension is in Zone 3 of Medicine, and in Zone 3 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Hypertension?
The latest impact factor listed by LetPub is 5.24; CiteScore 7.1, h-index 238.
How long does peer review take at Journal of Hypertension?
Based on the dates recorded on 27 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 93–187 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Hypertension in?
The journal's website gives JCR Q1; by category, PERIPHERAL VASCULAR DISEASE Q1 (16/100). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Journal of Hypertension?
According to LetPub and DOAJ records, Journal of Hypertension is indexed in SCIE and Scopus.
Is Journal of Hypertension open access, and what is the APC?
Journal of Hypertension is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .